Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Lung Neoplasms × NET × Clear all

Phase

Phase 1/2 3 Phase 2 2 Phase 1 2 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 50 Breast 15 Gastrointestinal 14 Genitourinary 9 Head & Neck 7 Gynecologic 6 Sarcoma 5 CNS 5 Dermatologic 4 Endocrine 2 Other solid neoplasm 1 NET 1

Conditions

Neuroendocrine Tumors 16 von Hippel-Lindau Disease 1 Pheochromocytoma 1 Paraganglioma 1 Neuroblastoma 1 Multiple Endocrine Neoplasia Type 1 1 Meningioma 1 Lung Neoplasms 1 Gastro-enteropancreatic neuroendocrine tumor 1 Carcinoid Tumor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02817945 2022-04-07

Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Unknown

EndocrineNETThoracic

Lung Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡